NCI’s Proteome Characterization Centers Announced
The National Cancer Institute (NCI) announces the launch of a Clinical Proteomic Tumor Analysis Consortium (CPTAC). Click here to find out more information about the newly announced centers.
PCCs Announced
Connecting Genome to Proteome
What is Proteomics?Clinical Proteomic Tumor Analysis Consortium 
The National Cancer Institute (NCI), part of the National Institutes of Health, announced the launch of a Clinical Proteomic Tumor Analysis Consortium (CPTAC) in August 2011. CPTAC is a comprehensive and coordinated effort to accelerate the understanding of the molecular basis of cancer through the application of robust, quantitative, proteomic technologies and workflows. Read more.
PublicationsRSS
- Mertins P, Udeshi ND, Clauser KR, Mani DR, Patel J, Ong SE, Jaffe JD, Carr SA. (2011) iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics . [Epub ahead of print] View PubMed abstract.
- Whiteaker JR, Zhao L, Lin C, Yan P, Wang P, Paulovich AG. (2011) Sequential multiplexed analyte quantification using peptide immunoaffinity enrichment coupled to mass spectrometry. Mol Cell Proteomics . [Epub ahead of print] View PubMed abstract.
- Kuhn E, Whiteaker JR, Mani DR, Jackson AM, Zhao L, Pope ME, Smith D, Rivera KD, Anderson NL, Skates SJ, Pearson TW, Paulovich AG, Carr SA. (2011) Inter-laboratory evaluation of automated, multiplexed peptide immunoaffinity enrichment coupled to multiple reaction monitoring mass spectrometry for quantifying proteins in plasma. Mol Cell Proteomics . Epub ahead of print View PubMed abstract.
Launch Antibody Portal »
The Antibody Portal serves as a public resource of monoclonal antibodies made available by the NCI for the scientific community to support protein/peptide measurement and analysis efforts.
Questions About Cancer
- Visit www.cancer.gov
- Call 1-800-4-CANCER
- Use LiveHelp Online Chat